Guiyi Ji

492 total citations
21 papers, 284 citations indexed

About

Guiyi Ji is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Guiyi Ji has authored 21 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Pharmacology. Recurrent topics in Guiyi Ji's work include Drug-Induced Hepatotoxicity and Protection (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Guiyi Ji is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Guiyi Ji collaborates with scholars based in China, Canada and United States. Guiyi Ji's co-authors include Ting Bao, Weimin Li, Jian‐Qing He, Andrew J. Sandford, Huairong Tang, Zhixi Su, Guowei Che, Yinyun Ni, Lingling Tan and Ling Yang and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Guiyi Ji

19 papers receiving 279 citations

Peers

Guiyi Ji
Wenhui Zhu China
Huiling Liu China
Wenjun Jia China
Huimin Ma China
Jaspreet Kaur India
Zhaoyang Lu China
Christel H. Kamani Switzerland
Xingdong Cai China
Angelica Intini Italy
Wenhui Zhu China
Guiyi Ji
Citations per year, relative to Guiyi Ji Guiyi Ji (= 1×) peers Wenhui Zhu

Countries citing papers authored by Guiyi Ji

Since Specialization
Citations

This map shows the geographic impact of Guiyi Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiyi Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiyi Ji more than expected).

Fields of papers citing papers by Guiyi Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guiyi Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiyi Ji. The network helps show where Guiyi Ji may publish in the future.

Co-authorship network of co-authors of Guiyi Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Guiyi Ji. A scholar is included among the top collaborators of Guiyi Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guiyi Ji. Guiyi Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Qian, Zheng, et al.. (2025). Enhancing cancer risk awareness and screening management through artificial intelligence: a narrative review. Frontiers in Oncology. 15. 1695749–1695749.
3.
Wang, Wei, Yi Liu, Tingting Song, et al.. (2025). Proteomic Analysis of Plasma Exosomes Enables the Identification of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease. Thoracic Cancer. 16(1). e15517–e15517. 1 indexed citations
4.
Bao, Ting, Bingqing Liu, Ruicen Li, et al.. (2024). LDCT screening results among eligible and ineligible screening candidates in preventive health check-ups population: a real world study in West China. Scientific Reports. 14(1). 4848–4848. 1 indexed citations
5.
Li, Ruicen, Guoqing Wang, Wenjuan Tao, et al.. (2024). Application of artificial intelligence in lung cancer screening: A real‐world study in a Chinese physical examination population. Thoracic Cancer. 15(28). 2061–2072. 4 indexed citations
6.
7.
Wang, Zhoufeng, Zhe Li, Kun Zhou, et al.. (2021). Deciphering cell lineage specification of human lung adenocarcinoma with single-cell RNA sequencing. Nature Communications. 12(1). 6500–6500. 98 indexed citations
8.
Tan, Lingling, Guiyi Ji, Ting Bao, et al.. (2021). Diagnosing sarcopenia and myosteatosis based on chest computed tomography images in healthy Chinese adults. Insights into Imaging. 12(1). 163–163. 28 indexed citations
9.
Ji, Guiyi, Ting Bao, Zhenzhen Li, et al.. (2021). Current lung cancer screening guidelines may miss high-risk population: a real-world study. BMC Cancer. 21(1). 50–50. 34 indexed citations
10.
Ji, Guiyi, Miaomiao Zhang, Qianqian Liu, et al.. (2021). Functional Polymorphism in the NFE2L2 Gene Associated With Tuberculosis Susceptibility. Frontiers in Immunology. 12. 660384–660384. 6 indexed citations
11.
Bao, Ting, Zhiye Ying, L. Gong, et al.. (2020). Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Nonobese Postmenopausal Women: A Cross-sectional Study. Scientific Reports. 10(1). 10072–10072. 23 indexed citations
12.
Wu, Shouquan, Qianqian Liu, Yu Wang, et al.. (2020). Association of heme oxygenase‐1 single nucleotide polymorphisms with susceptibility to tuberculosis in Chinese Han population. Journal of Clinical Laboratory Analysis. 34(7). e23276–e23276. 2 indexed citations
13.
Ji, Guiyi, Weiwei Huang, & Jian‐Qing He. (2019). Is anti-tuberculosis drug-induced hepatotoxicity due to a change in pharmacokinetics caused by alterations in antioxidant gene expression and polymorphisms in the NFE2L2 gene?. International Journal of Clinical Pharmacology and Therapeutics. 58(2). 67–73. 1 indexed citations
14.
Chen, Guo, Shouquan Wu, Mei Feng, et al.. (2017). Association of UGT2B7 polymorphisms with risk of induced liver injury by anti-tuberculosis drugs in Chinese Han. International Journal of Immunopathology and Pharmacology. 30(4). 434–438. 7 indexed citations
15.
Wu, Shouquan, Youjuan Wang, Xiaoyan Tang, et al.. (2016). Genetic Polymorphisms of Glutathione S-Transferase P1 (GSTP1) and the Incidence of Anti-Tuberculosis Drug-Induced Hepatotoxicity. PLoS ONE. 11(6). e0157478–e0157478. 17 indexed citations
16.
Ji, Guiyi, et al.. (2016). Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a prospective study. Genetics and Molecular Research. 15(3). 4 indexed citations
17.
Ji, Guiyi, Xuemei Zeng, Andrew J. Sandford, & Jian‐Qing He. (2016). Rifampicin-induced antineutrophil cytoplasmic antibody-positive vasculitis: a case report and review of the literature. International Journal of Clinical Pharmacology and Therapeutics. 54(10). 804–807. 12 indexed citations
18.
Wang, Yu, Guiyi Ji, Shouquan Wu, et al.. (2016). Analysis of silent information regulator 1 (SIRT1) gene polymorphisms in antituberculosis- drug-induced hepatotoxicity in a prospective cohort study. International Journal of Clinical Pharmacology and Therapeutics. 54(10). 775–781. 2 indexed citations
19.
Liu, Qianqian, Jing Wang, Andrew J. Sandford, et al.. (2015). Association of CYBB polymorphisms with tuberculosis susceptibility in the Chinese Han population. Infection Genetics and Evolution. 33. 169–175. 14 indexed citations
20.
Ji, Guiyi, et al.. (1988). Serial propagation of mammalian cells on gelatin‐coated microcarriers. Biotechnology and Bioengineering. 32(8). 1037–1052. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenhui Zhu Breakdown of academic impact, for papers by Huiling Liu Breakdown of academic impact, for papers by Wenjun Jia Breakdown of academic impact, for papers by Huimin Ma Breakdown of academic impact, for papers by Jaspreet Kaur Breakdown of academic impact, for papers by Zhaoyang Lu Breakdown of academic impact, for papers by Christel H. Kamani Breakdown of academic impact, for papers by Xingdong Cai Breakdown of academic impact, for papers by Angelica Intini
Rankless by CCL
2026